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Diagnostic value of markers of oxidative 
stress and metabolic disorders in preterm 
infants in the early neonatal period
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The aim of the study was to evaluate the markers of oxidative stress and metabolic disorders in preterm infants and to examine their 
association with short-term outcomes in the early neonatal period to identify the predictors of unfavourable outcome. The study 
included 46 preterm infants, gestational age ≤32 weeks, in the early neonatal period, i.e. group 1 of 12 infants with lethal outcome 
and group 2 of 34 preterm infants with favourable outcome. Markers of metabolic disorders, oxidative stress and antioxidant system 
were analysed in cord blood and urine on the fi rst/second day of life. Evaluation of oxidative (8-isoprostane) and antioxidant system 
(catalase and superoxide dismutase (SOD) activity) and metabolic (lactate, pyruvate, lactate to pyruvate ratio (LPR), NAD+/NADH) 
stress parameters confi rmed energy imbalance and presence of tissue hypoxia in preterm newborns with adverse outcomes. The 
following risk factors of unfavourable prognosis in preterm infants in the early neonatal period were identifi ed: asphyxia (p=0.038), 
early-onset sepsis (p=0.003), intraventricular haemorrhage (p=0.029), hyperlactatemia (p=0.013), increased pyruvate level (p=0.002), 
increased LPR (p=0.008), decreased catalase (p=0.003) and SOD (p=0.001) activity. Logistic regression indicated that mortality rate 
was positively related to asphyxia, early-onset sepsis and lactate level, and negatively related to SOD activity. In conclusion, intensive 
oxidative and metabolic stress in preterm infants is associated with adverse outcomes in the early neonatal period. A combination 
of asphyxia and early-onset sepsis together with high lactate level and decreased SOD activity is a predictor of unfavourable out-
come in the early neonatal period.
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INTRODUCTION
Preterm infants are a special cohort of neonates with func-
tional immaturity and specifi c pathological conditions dur-
ing adaptation to extrauterine life. Low-birth weight (LBW) 
and very-low-birth weight (VLBW) infants are special risk 
groups due to the presence of hypoxia, reoxygenation and 
tissue hypoperfusion in the early neonatal period in combi-
nation with multisystem disturbances and high morbidity 
with proinfl ammatory cascade (1). The imbalance between 
the overproduction of free radicals and immature antioxi-
dant protective systems in preterm infants leads to an in-
creased risk of oxidative stress. Immaturity of the respiratory, 
digestive, immune and antioxidant systems along with nu-
merous medical interventions after preterm birth (resuscita-
tion, ventilation, parenteral nutrition, and blood transfu-
sions) exacerbate the level of oxidative stress (2, 3).
Oxidative stress is an integral pathogenic component of 
pathological conditions in premature infants. It takes an im-
portant role in the variety of ‘free radical related diseases of 
prematurity’, which contribute to and predetermine devel-
opment of bronchopulmonary dysplasia, sepsis, necrotiz-
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ing enterocolitis, intraventricular haemorrhage, periventric-
ular leukomalacia and retinopathy of prematurity, all of 
which aff ect the prognosis (3, 4).
Therefore, the aim of the study was to evaluate the markers 
of oxidative stress and metabolic disorders in preterm in-
fants and their association with short-term outcomes in the 
early neonatal period, and to identify the predictors of unfa-
vourable outcome.
PATIENTS AND METHODS
Study design and participants
A single-centre, cohort, prospective study was performed 
at the neonatal intensive care unit of a regional perinatal 
centre. The research included 46 preterm infants, gestation-
al age (GA) less than 32 weeks, in the early neonatal period 
(group 1: 12 infants with lethal outcome and group 2: 34 
preterm babies with favourable outcome). The research was 
conducted in accordance with the World Medical Associa-
tion Helsinki Declaration and was approved by the local 
Ethics Committee of the I. Horbachevsky Ternopil National 
Medical University (protocol No 43 issued on October 23, 
2017).
Prematurity (GA ≤32 weeks) and birth weight less than 1500 
g were the criteria for inclusion in the study. Exclusion crite-
ria were chromosomal disorders, congenital malformations 
and absence of parent consent.
METHODS
The investigation included clinical examination of infants 
and laboratory determination of markers in metabolic dis-
orders (lactate, pyruvate, lactate to pyruvate ratio (LPR), 
NAD+/NADH), oxidative stress (8-isoprostane, reactive oxy-
gen species (ROS)) and antioxidant system (catalase and 
superoxide dismutase (SOD) activity). Lactate and pyruvate 
levels in umbilical cord serum were measured by enzymatic 
methods using standard Sigma-Aldrich kits (Sigma-Aldrich 
Co. LLC, USA) followed by spectrophotometry/colorimetry 
at the appropriate wavelength. The NAD+/NADH ratio was 
assessed based on the lactate and pyruvate levels. The 
8-isoprostane concentration in urine was determined by 
enzyme-linked immunoassay (ELISA KitBuff er, Cayman 
Chemical, Michigan, USA) according to the manufacturer’s 
instructions. ROS in blood mononuclear cells were evaluat-
ed by a fl ow laser cytometer. Catalase and SOD activity in 
umbilical cord blood were determined by spectrophoto-
metric method. All markers were tested in cord blood and 
8-isoprostane concentration was analysed in urine on the 
fi rst/second day of life.
Statistical analysis
Statistical analysis was performed using StatSoft STATISTICA 
Version 13 (Tulsa, OK). Quantitative indices with non-normal 
distribution were expressed as median (Me) and lower (Lq) 
and upper (Uq) quartiles. Mann-Whitney test was used to 
compare the two groups. Kruskal-Wallis test was used to 
compare the groups with Bonferroni correction (p<0.017) in 
the next pairwise comparison of the groups. Two-tailed 
Fisher exact test was used to compare qualitative parame-
ters. Odds ratio (OR) and its 95% confi dence interval (95% 
CI) were calculated.
Prognostic model for mortality rate prediction in the early 
neonatal period was made in logistic regression.
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n is serial number of the predictor included in the equation.
Wald χ2 statistics was used to fi nd statistical signifi cance (p) 








Clinical and laboratory examination included 46 preterm 
infants with GA less than 32 weeks. There were 18 neonates 
were born at ≤28 weeks of gestation with birth weight less 
than 1000 g (extremely low birth weight (ELBW)) and 28 pa-
tients with GA 29-32 weeks and birth weight over 1000 g 
(VLBW). Analysis of clinical characteristics of preterm infants 
according to GA showed that birth weight was one of the 
important factors for neonatal morbidity and mortality 
(р<0.001). At the same time, there was no signifi cant gen-
der diff erence according to GA (р>0.05). There was no sig-
nifi cant diff erence in the neonatal morbidity incidence (re-
spiratory distress syndrome, early- and late-onset sepsis, in-
tracranial haemorrhages (subarachnoid, intraventricular), 
periventricular leukomalacia and bronchopulmonary dys-
plasia) according to GA (p>0.05). Only the prevalence of 
retinopathy of prematurity was signifi cantly higher among 
infants with GA ≤28 weeks (p<0.05) (Table 1).
All patients were divided into two groups depending on 
short-term outcomes in the early neonatal period. Group 1 
included 12 infants who died during the early neonatal pe-
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riod (7 ELBW and 5 VLBW newborns). Group 2 included 34 
preterm babies with favourable outcome.
Study results showed no diff erences in GA, sex and birth 
weight between groups 1 and 2 (р>0.05) (Table 2).
Early-onset sepsis with multiple organ failure, intraventricu-
lar haemorrhage grade ІІІ-IV and asphyxia were signifi cantly 
more common in group 1 (р<0.05) and were dominantly 
the main reasons for early neonatal mortality (Table 2).
It was found that the presence of asphyxia could increase 
mortality rate in the early neonatal period 25 times 
(OR=25.42; 95% CI=1.21-536.25; p<0.05); early-onset sepsis 
could increase this risk 10 times (OR=10.50; 95% CI=2.23-
49.52; p<0.05); and intraventricular haemorrhage 5 times 
(OR=4.80; 95% CI=1.17-19.64; p<0.05) (Table 2).
Evaluation of the oxidative and metabolic stress parameters 
yielded signifi cant diff erences between the groups (Table 
3). These fi ndings confi rmed energy imbalance and pres-
ence of tissue hypoxia in preterm babies, predominantly in 
group 1 as compared to group 2 (higher levels of lactate 
(р<0.001), pyruvate (р<0.02), LPR (р<0.001), 8-isoprostane 
(р<0.001), along with signifi cantly lower antioxidant system 
activity (SOD, catalase) (р<0.001) (Table 3).
Analysis of the NAD+/NADH ratio indices revealed signifi -
cant diff erence between the study groups (p<0.001) (Table 
3), that refl ected inhibition of redox processes at the cellular 
level and impaired metabolic processes in infants with un-
favourable outcome.
Hyperlactatemia increased mortality rate in the early neo-
natal period 40 times (OR=39.81; 95% CI=2.17-729.07; 
p=0.013); increased pyruvate level 14 times (OR=13.89; 95% 
CI=2.54-75.93; p=0.002); and increased LPR 51 times (OR=
51.09; 95% CI=2.77-941.01; p=0.008). Simultaneously, de-









Boys 8 (44.44) 19 (67.86)
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Asphyxia 2 (11.11) 1 (3.57) 0.552
Early-onset sepsis 4 (22.22) 7 (25.00) 0.999
Late-onset sepsis 8 (44.44) 7 (25.00) 0.208
Respiratory distress 
syndrome
11 (61.11) 12 (42.86) 0.365
Intracranial haemorrhag 9 (50.00) 9 (32.14) 0.354
Retinopathy of prematurity 11 (61.11) 7 (25.00) 0.029*
Congenital pneumonia 3 (16.67) 9 (32.14) 0.315
Patent ductus arteriosus 3 (16.67) 1 (3.57) 0.284
Necrotizing enterocolitis 0 (0) 7 (25.00) 0.032*
Periventricular 
leukomalacia
2 (11.11) 2 (7.14) 0.639
Anaemia of prematurity 8 (44.44) 10 (35.71) 0.758
Bronchopulmonary 
dysplasia
3 (16.67) 0 (0) 0.054
*statistically signifi cant
TABLE 2. Clinical characteristics of study groups
Parameter
Group
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creased activity of the antioxidant system increased the risk 
of early neonatal mortality (catalase: OR=91.67; 95% CI=
4.85-1733.61; p=0.003; and SOD: OR=14.00; 95% CI=2.89-
67.72; p=0.001.
Multivariate analysis with logistic regression was carried out 
to determine predictors of early neonatal mortality. Death 
of the patient was the binary logistic parameter (mortality 
outcome – 1; survival – 0). Gestational age, intraventricular 
haemorrhage, asphyxia, early-onset sepsis, lactate level, py-
ruvate level, NAD+/NADH, 8-isoprostane, ROS and SOD ac-
tivity were the independent predictors. Categorical factors 
(intraventricular haemorrhage, asphyxia and early-onset 
sepsis) were coded as 0 – absence of the event and 1 – pres-
ence of the event. Continuous factors were presented as 
absolute parameter levels.
Based on the results of logistic regression, only few variables 
had a signifi cant infl uence on the outcome (early neonatal 
mortality), i.e. asphyxia (p<0.001), early-onset sepsis (р<
0.05), lactate level (p<0.001), NAD+/NADH (p<0.05) and SOD 
activity (р<0.05), and were predictors of early neonatal mor-
tality (Table 4).
Therefore, mortality risk in preterm infants could be predict-







where Х is linear combination of predictors.
In our research,











 – asphyxia, X
2
 – early-onset sepsis, X
3
 – lactate level 
and X
4
 – SOD activity.
According to the obtained model, mortality rate was posi-
tively related to asphyxia, early-onset sepsis, lactate level, 
and negatively related to the SOD activity.
DISCUSSION
The results of our study confi rmed that the oxidative and 
metabolic stress indices in preterm infants could be used as 
indicators of the severity of perinatal pathology with signs 
of tissue hypoxia and for prediction of short-term outcomes 
in these patients.
Lactate is a product of cellular metabolism under anaerobic 
conditions, so its increased serum concentration indicates 
tissue hypoxia and may be caused by severe hypoxia of dif-
ferent origin and anaerobic metabolism (5). According to 
our study, signifi cantly higher levels of lactate and pyruvate 
were found in the group of infants with unfavourable out-
comes in the early neonatal period, thus confi rming them as 
markers of complex metabolic disorders in patients in critical 
conditions (6, 7) and predictors of severe complications. Our 
data are consistent with other studies which showed the 
 association of lactate/pyruvate levels with severe complica-
tions such as multiorgan failure, cardiogenic shock, septic 
endocarditis, and adverse disease outcome (8, 9).
The levels of lactate, pyruvate and lactate/pyruvate ratio are 
important predictors of neonatal morbidity, severity of peri-
natal tissue hypoxia, and short-term outcome prognosis. 
Thus, the high level of lactate in the fi rst hours of life is an 
early prognostic marker of neurological disorder after intra-
uterine hypoxia, as well as asphyxia (10), and is associated 
with unfavourable outcomes in preterm VLBW infants (11, 
12), which also coincides with our results.
TABLE 3. Parameters of metabolic and oxidative stress in study groups (Me (Lq; Uq))
Parameters Group 1n=12 (range)
Group 2
 n=34 (range) Mann-Whitney test
Lactate, mmol/L 7.34 (7.06 - 7.64) 4.12 (3.88 - 4.58) р<0.001*
Pyruvate, mmol/L 0.08 (0.08 - 0.09) 0.07 (0.06 - 0.08) р<0.02*
Lactate/pyruvate ratio 90.31 (84.47 - 98.50) 62.63 (51.73 - 68.98) р<0.001*
NAD+/NADH 123.05 (113.00 - 131.55) 177.35 (161.10 - 214.80) р<0.001*
8-isoprostane, mg/mL 625.45 (584.35 - 689.90) 577.10 (532.20 - 607.50) р<0.001*
Reactive oxygen species, IU 0.50 (0.40 -  0.57) 0.47 (0.43 - 0.52) р>0.05
Catalase, IU/mL 0.38 (0.36 - 0.40) 0.47 (0.42 - 0.50) р<0.001*
Superoxide dismutase, mmol/hour*L 1.38 (1.30 - 1.89) 2.46 (2.12 - 2.95) р<0.001*
*statistically signifi cant 
TABLE 4. Predictors of mortality in the early neonatal period 
(results of logistic regression)
Predictors Regression coeffi  cient, b Standard error p
Asphyxia 0.439 0.107 <0.001*
Early-onset sepsis 0.150 0.073 0.049*
Lactate 0.182 0.026 <0.001*
Superoxide dismutase -0.118 0.057 0.045*
*statistically signifi cant
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In our study, the NAD+/NADH ratio in preterm infants with 
severe perinatal pathology showed profound energy imbal-
ance and tissue hypoxia in the background of signifi cant 
microcirculatory systemic disorders, thus serving as an indi-
cator of unfavourable early neonatal outcome. Reduced 
and oxidized forms of NAD+ are the key components of the 
energy formation process. The balance of NAD+/NADH de-
termines the redox status of the cells along with their meta-
bolic activity and confi rms tissue damage in various patho-
logical conditions (13). Nicotinamide adenine dinucleotide 
(NADH) levels are thought to be the most sensitive indica-
tor of tissue oxygenation at the level of mitochondria and 
an early marker of death risk (14).
Perinatal pathology of premature infants, which is often ac-
companied by hypoxic episodes, recurrent apnoea, the 
need for resuscitation, ventilation support and additional 
oxygen supply contributes to the development of oxidative 
stress in these patients (15-17). Newborns, especially pre-
mature infants, have an immature protective antioxidant 
system and are especially vulnerable to oxidative stress, 
which is associated with neonatal morbidity, neurodevel-
opmental disorders, and increased mortality (4, 18-20).
F2-isoprostanes are important diagnostic indicators of oxida-
tive stress and its levels are evaluated in various pathologies 
(2). According to literature review, higher levels of isoprostane 
were detected in premature infants with respiratory disorders 
and manifestations of bronchopulmonary dysplasia com-
pared to preterm infants without respiratory pathology (21). 
Monitoring of 8-isoprostane in preterm infants with patent 
ductus arteriosus revealed its decreased level during ibupro-
fen therapy, confi rming the eff ectiveness of the proposed 
treatment (22). Our study showed the 8-isoprostane level in 
preterm infants to diff er signifi cantly between the groups, 
thus confi rming intensive oxidative stress in infants with un-
favourable outcomes in the early neonatal period.
The antioxidant system with its components (SOD and cata-
lase) is an important link in cellular protection against oxida-
tive stress and peroxidation processes. SOD participates in 
oxygen metabolism inside the cells, catalysing dismutation 
of superoxide radicals (O
2







), thus reducing the overall toxic 
eff ect of ROS. The catalase function is to prevent accumula-
tion of hydrogen peroxide by detoxifying it to oxygen and 
water (23).
The decreased activity of SOD, catalase in our study, coin-
cides with the results reported by Inayat et al. (24) regarding 
early detection and prognosis of hemodynamically signifi -
cant patent ductus arteriosus in premature infants with low 
birth weight. The study by Perrone et al. demonstrated 
strong correlation between the oxidative stress marker lev-
els and the occurrence of so-called free radical diseases in 
newborns (intraventricular haemorrhage, periventricular 
leukomalacia, patent ductus arteriosus and retinopathy of 
prematurity, bronchopulmonary dysplasia) (25).
According to the results of our study, increased levels of lac-
tate, lactate/pyruvate ratio and 8-isoprostane with signifi cant 
inhibition of antioxidant protection (decreased catalase and 
SOD activity) in premature infants are associated with ad-
verse prognosis in the early neonatal period and may be con-
sidered as risk factors for predicting early outcomes, which is 
consistent with other authors (26). The major limitation of this 
study was a small number of study subjects. 
CONCLUSIONS
High levels of lactate, pyruvate, lactate/pyruvate ratio, 8-iso-
prostane, along with a combination of decreased NAD+/
NADH ratio, activity of SOD and catalase indicate that inten-
sive oxidative and metabolic stress is associated with ad-
verse outcomes in premature infants in the early neonatal 
period. A combination of asphyxia and early-onset sepsis 
together with high lactate level and decreased SOD activity 
is a predictor of unfavourable outcome in the early neonatal 
period.
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S A Ž E T A K
Dijagnostička vrijednost biljega oksidativnog stresa 
i metaboličkih poremećaja kod nedonoščadi 
u ranom neonatalnom razdoblju
Halyna Pavlyshyn, Iryna Sarapuk, Kateryna Kozak, Olga Klishch
Cilj istraživanja bio je procijeniti biljege oksidativnog stresa i metaboličkih poremećaja kod nedonoščadi te ispitati njihovu udruženost 
s kratkoročnim ishodima u ranom neonatalnom razdoblju kako bi se utvrdili prediktori nepovoljnih ishoda. Istraživanje je obuhvatilo 
46 nedonoščadi gestacijske dobi ≤32 tjedna u ranom neonatalnom razdoblju: 1. skupina od 12 nedonoščadi sa smrtnim ishodom i 2. 
skupina od 34 nedonoščadi s povoljnim ishodom. Biljezi metaboličkih poremećaja, oksidativnog stresa i antioksidantnog sustava 
analizirani su u pupčanoj krvi i mokraći prvog i drugog dana života. Procjena parametara oksidativnog (8-izoprostan) i antioksi-
dantnog sustava (aktivnost katalaze i superoksid dismutaze (SOD)) te metaboličkog stresa (laktat, piruvat, omjer laktata i piruvata 
(LPR), NAD+/NADH) potvrdila je energetsku neravnotežu i prisutnost tkivne hipoksije kod novorođenčadi s lošim ishodom. Utvrđeni su 
sljedeći rizični čimbenici nepovoljne prognoze kod novorođenčadi u ranom neonatalnom razdoblju: asfi ksija (p=0,038), rana sepsa 
(p=0,003), intraventrikulsko krvarenje (p=0,029), hiperlaktatemija (p=0,013), povišena razina piruvata (p=0,002), povišen LPR 
(p=0,008), snižena aktivnost katalaze (p=0,003) i SOD (p=0,001). Logistička regresija pokazala je da je stopa smrtnosti pozitivno pove-
zana s asfi jksijom, ranom sepsom i razinom laktata te negativno povezana s aktivnošću SOD. U zaključku, intenzivan oksidativni i 
metabolički stres kod nedonoščadi udružen je s nepovoljnim ishodima u ranom neonatalnom razdoblju. Kombinacija asfi ksije i rane 
sepse zajedno s visokom razinom laktata i sniženom aktivnošću SOD predviđa nepovoljan ishod u ranom neonatalnom razdoblju.
Ključne riječi: METABOLIČKI POREMEĆAJI; OKSIDATIVNI STRES; NEDONOŠČAD 
